Výsledky vyhledávání

[Untitled]

Autor: Gian Franco Gensini, Luc Vittori, Ari Timerman, Harvey D. White, Nicolas Danchin, Veronique Le-Louer, Keith A.A. Fox, Frans Maritz, Frederique Bigonzi, Kurt Huber, Marc Cohen, Enrique P. Gurfinkel

Publikováno v: Journal of Thrombosis and Thrombolysis. 10:241-246

Patients with acute myocardial infarction (AMI) who do not receive early reperfusion therapy are at high risk of reinfarction or death, and the efficacy and safety of antithrombotic therapy in this group of patients has not been evaluated. Enoxaparin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6a3ca39e942e340c81701c0c010dc29c
https://doi.org/10.1023/a:1026543107533

Zobrazit plný text záznamu

Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial

Autor: Marc Cohen, Frans Maritz, Maria Krzemińska-Pakuła, Carole Hecquet, Enrique P. Gurfinkel, Jose Santopinto, Kurt Huber, Luc Vittori, Ari Timerman, Gian Franco Gensini

Publikováno v: Circulation. 108(16 Suppl 1)

Background— Treatment with lytics or primary percutaneous coronary interventions (PCI) reduces the mortality rate of patients with ST-elevation myocardial infarction (STEMI) presenting within 12 hours. Patients presenting >12 hours are generally co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28565ab220a65936c18a21ff6d7bd050
https://pubmed.ncbi.nlm.nih.gov/14605015

Zobrazit plný text záznamu

Use of reperfusion therapy in patients presenting with ST elevation myocardial infarction: Findings from the TETAMI study and TETAMI registry (the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction)

Autor: Frans Maritz, Marc Cohen, Luc Vittori, Ari Timerman, Harvey D. White, Kurt Huber, Maria Krzemińska-Pakuła, Enrique P. Gurfinkel, Nicolas Danchin, Gian Franco Gensini

Publikováno v: Journal of the American College of Cardiology. 41(6)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa3c2cbc911e27c3cb829bf2503c7a5

Zobrazit plný text záznamu

Underuse of reperfusion therapy in female patients: Insights from the TETAMI study and registry (The safety and efficacy of subcutaneous Enoxaparin versus intravenous unfractionated heparin and of myocardial infarction)

Autor: Kurt Huber, Frans Maritz, Marc Cohen, Gian Franco Gensini, Ari Timerman, Maria Krzemińska-Pakuła, Nicolas Danchin, Enqrique P. Gurfinkel, Harvey D. White, Luc Vittori

Publikováno v: Journal of the American College of Cardiology. 41:358

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f375d7410178126555728de5e8de51
https://doi.org/10.1016/s0735-1097(03)82118-6

Zobrazit plný text záznamu

The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI) A randomized trial

Autor: Kurt Huber, Marc Cohen, Enrique P. Gurfinkel, Frans Maritz, Luc Vittori, Jose Santopinto, Maria Krzemińska-Pakuła, Frederique Bigonzi, Ari Timerman, Tetami Investigators, Nicolas Danchin, Harvey D. White, Carole Hecquet, Gian Franco Gensini

Publikováno v: Journal of the American College of Cardiology. (8):1348-1356

Objectives The aims of the Safety and Efficacy of Subcutaneous Enoxaparin Versus Intravenous Unfractionated Heparin and Tirofiban Versus Placebo in the Treatment of Acute ST-Segment Elevation Myocardial Infarction Patients Ineligible for Reperfusion

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5bd1fb545b90c64fbb6e27890eb036

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání